Results 141 to 150 of about 238,371 (341)

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Circulating neuregulin-1 and galectin-3 can be prognostic markers in breast cancer [PDF]

, 2017
Background: It is important to identify novel plasmatic biomarkers that can contribute to assessing the prognosis and outcome of breast cancer patients.
Cardelli, Patrizia, DE IULIIS, Francesca, Lanza, Rosina, Salerno, Gerardo, Scarpa, Susanna, Taglieri, Ludovica   +5 more
core   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile. [PDF]

, 2016
PurposeWe have established a prospective cohort of 1959 patients with chronic Chagas cardiomyopathy to evaluate if a clinical prediction rule based on ECG, brain natriuretic peptide (BNP) levels, and other biomarkers can be useful in clinical practice ...
Bierrenbach, Ana Luiza, Cardoso, Clareci Silva, Cunha-Neto, Edécio, de Oliveira, Lea Campos, Ferreira, Ariela Mota, Ferreira, João Eduardo, Haikal, Desirée Sant'Ana, Oliveira, Claudia Di Lorenzo, Reingold, Arthur L, Ribeiro, Antonio Luiz P, Sabino, Ester Cerdeira   +10 more
core   +3 more sources

NT-proBNP for risk stratification of pulmonary embolism

Revista Portuguesa de Cardiologia (English Edition), 2011
Pulmonary embolism (PE) is an entity with high mortality and morbidity, in which risk stratification for adverse events is essential. N-terminal brain natriuretic peptide (NT-proBNP), a right ventricular dysfunction marker, may be useful in assessing the short-term prognosis of patients with PE.To characterize a sample of patients hospitalized with PE ...
Hélder, Dores, Cândida, Fonseca, Sílvio, Leal, Ingrid, Rosário, João, Abecasis, José, Monge, Maria João, Correia, Luís, Bronze, Ana, Leitão, Isabel, Arroja, Ana, Aleixo, Aniceto, Silva   +11 more
openaire   +2 more sources

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Clinical Research in Cardiology, 2019
Background In heart failure (HF), levels of NT-proBNP are influenced by the presence of concomitant atrial fibrillation (AF), making it difficult to distinguish between HF versus AF in patients with raised NT-proBNP.
B. Santema, Michelle M. Y. Chan, J. Tromp, M. Dokter, H. H. van der Wal, J. E. Emmens, J. Takens, N. Samani, L. Ng, C. Lang, P. van der Meer, J. T. ter Maaten, K. Damman, K. Dickstein, J. Cleland, F. Zannad, S. Anker, M. Metra, P. van der Harst, Rudolf A. de Boer, D. V. van Veldhuisen, M. Rienstra, C. Lam, A. Voors   +23 more
semanticscholar   +1 more source

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease

Perioperative Medicine
Objective We aimed to probe the clinical value of N-terminus pro-brain natriuretic peptide (NT-proBNP), myeloperoxidase (MPO), and neutrophil lymphocyte ratio (NLR) combined with echocardiography in the prediction of malignant arrhythmias (MA) in elderly
Jianping Liu, Apei Zhou, Meiduan Zheng, Ling Wang, Ping Zeng   +4 more
doaj   +1 more source

NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.

Stroke, 2019
Background and Purpose- NT-proBNP (N-terminal pro-B-type natriuretic peptide) is a risk factor for atrial fibrillation and a marker of cardiac function used in the detection of heart failure.
A. Di Castelnuovo, G. Veronesi, S. Costanzo, T. Zeller, R. Schnabel, A. De Curtis, V. Salomaa, R. Borchini, M. Ferrario, S. Giampaoli, F. Kee, S. Söderberg, T. Niiranen, K. Kuulasmaa, G. de Gaetano, M. Donati, S. Blankenberg, L. Iacoviello   +17 more
semanticscholar   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood [PDF]

, 2017
Background: The Roche CARDIAC proBNP point-of-care (POC) test is the first test intended for the quantitative determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) in whole blood as an aid in the diagnosis of suspected congestive heart ...
Collinson, Paul O., Dikkeschei, Bert, Gaze, David C., Guerti, Khadija, Gurr, Eberhard, Haass, Markus, Hayen, Wiebke, Hechler, Christoph, Katus, Hugo A., Klopprogge, Kai, Nelles, Manfred, Printzen, Gert, Schulz, Ilse, van Hoof, Viviane, van Waes, Carl, Zerback, Rainer, Zugck, Christian   +16 more
core